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Abstract
The vast majority of periodontal pathogens are classified as gram negative bacteria. These bacteria have
an outermost membrane consisting of lipopolysaccharide (LPS), a molecule that can act as an endotoxin
and elicit an immune response. The lipopolysaccharide structure consists of three major regions:
oligosaccharide, core, and lipid A. Oligosaccharide is exposed on the cell surface, and lipid A anchors LPS
in the outer membrane. LPS has been known to hinder certain defensive mechanisms of the immune
system by secreting products that interfere with signals that promote chemotaxis of leukocytes enabling
the pathogens to go unrestricted. When LPS binds to the Toll‑like receptor it promotes the secretion of
proinflammatory cytokines in cells such as the macrophage, monocyte, and endothelial cells. Two such
cytokines stimulated by LPS are macrophage inflammatory protein 1‑alpha (MIP‑1α) and interleukin 8
(IL‑8) both of which have been characterized as potent monocyte chemoattractants. IL‑8 has potency as
a chemotactic agent equal to that of C5a. It is a pro-inflammatory mediator of gingivitis and a mediator of
the inflammatory response, by serving as a chemical signal that attracts neutrophils. MIP‑1α belongs to a
large super family of small inducible cytokines. It is able to stimulate the activity of white blood cells in
response to infection or inflammation and is a major factor produced by macrophages stimulated with
bacterial endotoxins. The present study examined the interaction of LPS prepared from periodontal
pathogens with monocytes, to stimulate them to secrete MIP‑1α and IL‑8. The hypothesis of this study is
that LPS molecules of more pathogenic periodontal pathogens suppress the secretion of both MIP‑1α
and IL‑8, in such a way that they can escape detection by the defensive cells, thus facilitating their ability
to colonize the oral cavity and may contribute to their pathogenicity.
The LPS from three different periodontal pathogens, Porphyromonas gingivalis, Prevotella denticola, and
Fusobacterium nucleatum were isolated under identical conditions. Cultured human monocytic cells were
incubated with different concentrations of LPS and then the secretion of MIP‑1α and IL‑8 was measured
by enzyme‑linked immunosorbent assay (ELISA).
The results demonstrated that LPS of different periodontal pathogens differ in their ability to stimulate
inflammatory cytokines. LPS of P. gingivalisand P. denticola were found to suppress the secretion of both
IL‑8 and MIP‑1α at higher concentrations. On the other hand, LPS of F. nucleatumstimulated the secretion
of IL‑8 and MIP‑1α, by monocytes in a dose dependent manner.
The long term objective is to understand the mechanisms by which the periodontal pathogens escape
detection by interfering with host defensive functions, such as chemotaxis. This study presents a
possible mechanism of chemotaxis interference by LPS from periodontal pathogens by inhibiting the
secretion of both MIP‑1α and IL‑8. With an understanding of the mechanism by which LPS molecules
interfere with chemotaxis, it may be possible to intervene and prevent the tissue destruction associated
with periodontal pathogens.
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ABSTRACT
The vast majority of periodontal pathogens are classified as gram negative
bacteria. These bacteria have an outermost membrane consisting of lipopolysaccharide
(LPS), a molecule that can act as an endotoxin and elicit an immune response. The
lipopolysaccharide structure consists of three major regions: oligosaccharide, core, and
lipid A. Oligosaccharide is exposed on the cell surface, and lipid A anchors LPS in the
outer membrane. LPS has been known to hinder certain defensive mechanisms of the
immune system by secreting products that interfere with signals that promote chemotaxis
of leukocytes enabling the pathogens to go unrestricted. When LPS binds to the Toll-like
receptor it promotes the secretion of proinflammatory cytokines in cells such as the
macrophage, monocyte, and endothelial cells. Two such cytokines stimulated by LPS are
macrophage inflammatory protein 1-alpha (MIP-1α) and interleukin 8 (IL-8) both of
which have been characterized as potent monocyte chemoattractants. IL-8 has potency as
a chemotactic agent equal to that of C5a. It is a pro-inflammatory mediator of gingivitis
and a mediator of the inflammatory response, by serving as a chemical signal that attracts
neutrophils. MIP-1α belongs to a large super family of small inducible cytokines. It is
able to stimulate the activity of white blood cells in response to infection or inflammation
and is a major factor produced by macrophages stimulated with bacterial endotoxins. The
present study examined the interaction of LPS prepared from periodontal pathogens with
monocytes, to stimulate them to secrete MIP-1α and IL-8. The hypothesis of this study is
that LPS molecules of more pathogenic periodontal pathogens suppress the secretion of
both MIP-1α and IL-8, in such a way that they can escape detection by the defensive
cells, thus facilitating their ability to colonize the oral cavity and may contribute to their
pathogenicity.
The LPS from three different periodontal pathogens, Porphyromonas gingivalis,
Prevotella denticola, and Fusobacterium nucleatum were isolated under identical
conditions. Cultured human monocytic cells were incubated with different concentrations
of LPS and then the secretion of MIP-1α and IL-8 was measured by enzyme-linked
immunosorbent assay (ELISA).
The results demonstrated that LPS of different periodontal pathogens differ in
their ability to stimulate inflammatory cytokines. LPS of P. gingivalis and P. denticola
were found to suppress the secretion of both IL-8 and MIP-1α at higher concentrations.
On the other hand, LPS of F. nucleatum stimulated the secretion of IL-8 and MIP-1α, by
monocytes in a dose dependent manner.
The long term objective is to understand the mechanisms by which the
periodontal pathogens escape detection by interfering with host defensive functions, such
as chemotaxis. This study presents a possible mechanism of chemotaxis interference by
LPS from periodontal pathogens by inhibiting the secretion of both MIP-1α and IL-8.
With an understanding of the mechanism by which LPS molecules interfere with
chemotaxis, it may be possible to intervene and prevent the tissue destruction associated
with periodontal pathogens.
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CHAPTER 1.

INTRODUCTION AND LITERATURE REVIEW
Periodontitis and Inflammation

Periodontal disease is an infection of the attachment apparatus leading to the
destruction of the alveolar process and connective tissue that support the tooth, with the
end sequelae being tooth loss. Periodontal disease is initiated by plaque which is
composed of numerous types of bacteria that produce toxins which in turn stimulate a
chronic inflammatory response in which the body in essence turns on itself, destroying
the tissues and bone that support the teeth.1 Studies have been performed to evaluate the
composition of the subgingival biofilm and identified key periodontal pathogens by both
cultivation and molecular methods. More than 700 different species have been identified
in the oral cavity, many of which are yet to be cultivated.2
According to the National Institute of Dental Research, periodontal disease is one
of the most common human diseases. It has been estimated that around 80% of all adults
are affected with at least one site having clinical attachment loss of greater than two
millimeters (mm).3 This number increases to around 90% for those aged 55 to 64 having
at least one site with greater than 2 mm of clinical attachment loss.4 The incidence of
periodontal disease is increasing in parallel with the ability of the adult population to
retain their dentition for longer time periods. Despite the continued efforts of dental
professionals to treat this disease by both surgical and non-surgical methods, prevention
of the disease appears to be at times impossible. The inability to prevent disease has been
recognized to be due to the complications inherent in the role of bacterial modulation of
the immune system. Recently more and more literature has been published that
demonstrate an association between a variety of systemic diseases and periodontal
disease. Loe et al., has described periodontal disease as the sixth complication of
diabetes.5 While other studies have demonstrated diseases such as diabetes, heart disease,
respiratory diseases, Alzheimer's and osteoporosis are associated with periodontal
disease.6
Inflammation has been found to be a causative factor of both periodontal disease
and various systemic diseases in a susceptible host. There is both a local inflammatory
response in the periodontium and a systemic inflammatory response throughout the body
in people who also suffer from one of the diseases linked to periodontal disease. This is
significant because treating the individual's periodontal disease reduces overall
inflammation, which may help alleviate some of their symptoms from other diseases.
Likewise, lowering the total body inflammation may help quell some of the periodontal
symptoms and inflammation. However, the mechanisms associated with these
inflammatory diseases are poorly understood. Interaction of bacterial products and
antigens of periodontal pathogens elicits a host response which engages inflammatory
cells resulting in the release of cytokines. Some recent studies suggest the up-regulation
of proinflammatory cytokines such as tumor necrosis factor-alpha (TNFα) and
interleukin-1beta (IL-1). These are primarily products of innate immune cells such as
macrophages and neutrophils. In addition they play a key role in the chronic
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inflammatory lesion.7 These cytokines stimulate and activate resident fibroblasts in the
periodontal tissues to produce matrix metalloproteinase (MMP) and other proteases,
which degrade the surrounding connective tissue. These cytokines have been shown to be
potent stimulators of local osteoclastogenesis, which leads to efficient degradation of
periodontal tissues.7 Periodontitis may involve both the direct cytotoxic and proteolytic
effects of oral microorganisms and the indirect pathologic consequences of the host
immune response to these microorganisms.8 Aggregatibacter actinomycetemcomitans
(Aa), Porphyromonas gingivalis (P. gingivalis), and Tannerella forsythia (Tf) have been
implicated as principal anaerobic gram-negative bacteria in adult periodontitis.8 A wide
variety of virulence factors, including lipopolysaccharide (LPS), fimbriae,
haemagglutinin, leukotoxin, cytolethal distending toxin, and haemolysins have
contributed to the pathogenicity of these organisms.9
Pathogens Associated with Periodontal Disease
The change from periodontal health to disease is often associated with the
displacement of a predominantly gram-positive bacterial flora in the gingival crevice by
gram-negative anaerobes. A small number of gram-negative species have been
consistently associated with specific forms of periodontal disease among these are
P. gingivalis, Tf, and Fusobacterium nucleatum.8 These organisms are implicated in the
damage of tissue through virulence factors such as fimbriae, capsule, and endotoxin and
through deregulation of the host’s innate and acquired immunity systems.9 Slots et al.,
studied adults with advanced chronic periodontitis and reported Aa in 50% of progressing
lesions but in only 6% of non-progressing lesions. P. gingivalis was seen in 42% to 52%
of progressing lesions and was seen in 14% of non-progressing sites. Prevotella
intermedia was found in 59% to 89% of progressing lesions and from 36% to 53% of
non-progressing sites.10 P. gingivalis is categorized as part of the red complex bacterium
as it is associated with the more severe forms of periodontitis. In addition, it is grouped
with the black pigmented bacteria due to its ability to accumulate hemin which serves the
purpose of providing an iron source for growth. The organism appears to lack the ability
to secrete known iron chelating compounds and must use alternate mechanisms to
sequester and transport exogenous iron. P. gingivalis possesses an armamentarium of cell
surface-associated and extracellular activities, which are studied for their virulence
potential. Ginigipains is an example of one such virulence factor secreted by P.
gingivalis, work to degrade cytokines and down regulate the host response. Other
virulence factors are putative adhesins which interact with other bacteria, epithelial cells,
and extracellular matrix proteins. The virulence factors can be secreted or cell-bound
enzymes, toxins, or haemolysins and have been shown to play a significant role in the
spread of the microorganisms through tissue, in tissue destruction, and in evasion of host
defenses.11
The lipopolysaccharide of P. gingivalis is not inhibited in human serum and can
induce production of IL-1α by macrophages and monocytes. In addition, P. gingivalis has
a hydrocarbon structure with high antigenic and immunogenic potency that triggers an
IgG response.11 This decreases the effectiveness of the complement pathway of the
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immune system.12 Furthermore it was demonstrated by Cutler et al. that the opsonization
and clearance of P. gingivalis by neutrophils required the response of specific IgG-type
antibodies.13 Antibodies which neutralize P. gingivalis enzymes are essential to ensure
the normal phagocytic activity of neutrophils when the alternative complement pathway
is ineffective. Hence, these antibodies do not function as opsonins but rather serve to
neutralize toxic bacterial products, such as proteases.
Although not as prevalent as P. gingivalis, Prevotella species are a major portion
of the microflora of human gingival crevices in patients with periodontal disease.14 The
similarity of the phenotypic characteristics of these species often makes their routine
differentiation and identification difficult.14 P. intermedia is one of the organisms of the
Prevotella species associated with periodontal disease. Current evidence indicates that
the prevalence of subgingival species such as putative periodontal pathogens (being more
evident in the orange and red complexes) varies between geographical locations and
ethnic groups.9 In a study carried out by Maestre et al., the isolation rate of anaerobic
periodontal pathogens in patients with periodontitis was 60% Prevotella buccae, 40%
Prevotella denticola, 38% F. nucleatum, 35% P. intermedia and 23% Veillonella.15 P.
intermedia colonizes early in the infection process, and like other oral bacteria it can bind
and co-aggregate with other bacteria, and can adhere to epithelial cells. It has the added
benefit in that it carries antibiotic resistant genes, and may be responsible for antibiotic
resistance in disease progression. It has tissue degradation properties which are derived
from proteases and haemolysin.
F. nucleatum is an anaerobe, with a high capacity to adapt to and reduce an
oxygenated environment. It is commonly isolated from human subgingival plaques
associated with both healthy and periodontally diseased sites.16 The organisms have been
found in subgingival sites associated with long-standing gingivitis, in association with
spirochetes in lesions of acute necrotizing ulcerative gingivitis, and in periodontitis.16,17
F. nucleatum is also regarded as a key organism for dental plaque maturation due to its
extensive co-aggregating capacity.18 Bradshaw et al., have suggested that F. nucleatum
could be a bridge or mediator of co-aggregation between facultative and obligate
anaerobic species. They proposed that this co-aggregation was the mechanism by which
strict anaerobes, such as P. gingivalis, survive under aerobic conditions, due to the
formation of microenvironments in which facultative organisms reduce oxygen tension.19
The host response is of equal importance to bacteria in the etiology of periodontal
disease. The host response to periodontal pathogens involves numerous aspects of the
immune system. Individual susceptibility to periodontal pathogens is of great importance
in determining the onset and extent of periodontitis. Therefore it is necessary to
understand the factors that influence susceptibility to periodontitis, which include
environmental risk factors and genetic variance. In addition, it is also important to
understand the mechanisms by which the immune system operates to protect an
individual from injury as a result of colonization by pathogenic bacteria. The complement
system is part of the innate immune system and functions to aid the ability of antibodies
and phagocytic cells to clear pathogens from the host. This system can be activated by
either the classical or alternative pathway. In the alternative complement pathway a
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specific antibody is not needed for the commencement of an immune response, and
therefore activation takes place much faster. The caveat of this faster activation is that
only specific types of antigens can activate this pathway; one such molecule is LPS. The
classical complement pathway detects antibody-antigen complexes and eventually results
in bacterial opsonization. Activation of the complement system is one of the earliest host
immune responses in the gingival crevicular space. The presence of bacteria in the
gingival pocket can activate this system by either the classical or alternative pathway.20
The recruitment of neutrophils is another mechanism the body uses in the defense against
periodontal pathogens. Neutrophil infiltration is the first line of defense against
periodontal pathogens, and the associated inflammatory cell infiltrate in gingival tissue
and GCF is predominantly formed by neutrophils.21 When neutrophils become
ineffective, the second line of defense is the recruitment of monocytes which function as
phagocytic cells. It has been postulated that neutrophils follow the concentration gradient
of interleukin 8 (IL-8) and move from cell to cell via the inter-cellular adhesion molecule
(ICAM) receptor.22 In the gingival pocket, active neutrophils attempt microbial
elimination by phagocytosis. However, some of the periodontal pathogens are able to
evade the neutrophils, leading to an over production of phagocytes in the gingival crevice
which in turn gives rise to degranulation due to ineffective phagocytosis.23 Degranulation
of the polymorphonuclear leukocyte (PMN) is accompanied by the release of endogenous
proteases that, alongside the bacterial proteases, produce degradation of the cell matrix
causing continuous destruction of the periodontal tissue.23
Lipopolysaccharide and Gram-Negative Bacteria
Lipopolysaccharide is a molecule in which lipids and polysaccharides are linked
via covalent bonds. The molecule acts as an endotoxin and is located on the outer
membrane of gram-negative bacteria where it can elicit a strong immune response in
animals.24 LPS is an extremely potent toxin stimulating macrophage activation at
concentrations of LPS as low as 1 pg/mL. Three major receptors expressed on the surface
of monocytes and macrophages are known to bind to LPS. These include CD14, the
macrophage scavenger receptor, and the 2 leukocyte integrins.25 The CD14 receptor is
capable of initiating signals to a cell, resulting in phagocyte activation, bacterial
internalization, and the activation of bactericidal defenses.
When LPS binds to the CD14 receptor, it promotes the secretion of
proinflammatory cytokines in cells such as the macrophage.24 The periodontal pathogens
such as P. gingivalis secrete LPS, initiating a cascade of events leading to the release of
various inflammatory mediators. Once secreted, LPS may then enter the plasma. Upon
entrance of LPS into the plasma it is then either inactivated by one of the plasma proteins
or it binds the LPS-binding protein (LBP).25 LBP is an acute phase reactant, synthesized
by hepatocytes, which catalyses LPS transfer to its receptor, membrane CD14 present in
monocytes /macrophages or soluble CD14 (sCD14).26 When LPS binds to the protein
carrier LBP, it allows binding to CD14 receptors on activated monocytes, which results
in attachment to the cell wall and begins cellular activation. In the presence of LBP, the
sensitivity of monocytes to LPS may be as high as 100 to 1000 fold.26 LPS secreted by P.
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gingivalis is thought to interact with receptors such as Toll-like receptors (TLR). If LPS
is bound to TLR-2 it activates epithelial cells and if bound to TLR-4 it activates
endothelial cells. Both of which when stimulated by P. gingivalis LPS produces
proinflammatory cytokines.27 The type of cytokine produced is thought to be dependent
upon the LPS structure, via Lipid A moieties that contribute to induce different cellular
effects.28,29 An alternate hypothesis is that the type of cytokine produced is due to
lipoproteic contaminants of LPS.30
It has been demonstrated that individuals with periodontal disease have greater
CD14 levels as compared to healthy individuals.31 It has also been demonstrated that
there are increases in serum level of LBP and antibodies against LPS of periodontal
pathogens in patients with periodontitis.32
LPS has a unique structure (Figure 1-1) comprised of 3 major parts: O antigen,
core oligosaccharide, and lipid A.33 The O-antigen (also known as the O-polysaccharide)
is a repeating glycan polymer attached to the core oligosaccharide, and comprises the
outermost domain of the LPS molecule. It is this portion of the LPS that provides most of
the structural heterogeneity of the molecule.34 If the O antigen is absent from bacterial
LPS the molecule would be referred to as rough, due to the colonial morphology, where
as the presence of the O chains would render the molecule smooth.34
The structure of the O polysaccharide defines the O-antigen serological specificity
of an organism, but the numbers of unique O antigens within a species vary
considerably.35 Understanding LPS structural variation in bacterial pathogens is
important because the composition or size of the O-antigen might be a reliable indicator
of virulence potential.36 In general, the primary role(s) of the O antigen appears to be
protective and may contribute to bacterial evasion of host immune responses, particularly
the alternative complement cascade.33 The core oligosaccharide is a small chain of sugars
such as hexose and keto-deoxyoctulosonate (KDO). This portion of the LPS molecule is
extremely diverse among bacterial species and even within strains of species. It can be
divided into two portions: an inner core and an outer core. The inner core consists of 10
to 12 sugars and KDO. It is bound to lipid A via a ketosidic bond, which is susceptible to
acid cleavage. Therefore a weak acid may be used to separate the lipid and
polysaccharide portions of LPS.
Macrophage Inflammatory Proteins
Macrophage inflammatory proteins (MIP) belong to the family of chemotactic
cytokines known as chemokines. There are two major forms, MIP-1α and MIP-1β both of
which are produced by macrophages when stimulated with bacterial endotoxins.37 The
role of MIP-1 as it relates to periodontal disease remains to be elucidated. It has been
shown that MIP-1 acts to stimulate monocytes and/or osteoclast progenitor cells to
become active osteoclasts.38 MIP-1 was found elevated in patients with multiple
myeloma months before any radiographic detection of bone loss could be depicted.39
MIP-1 was also shown to be elevated in patients with periapical lesions.40 Studies have
5

Figure 1-1.

Diagram Representing the Structure of Lipopolysaccharide.

6

shown MIP-1 to be elevated in patients with periodontal disease and to be directly
correlated with increased probing depths.41 It has also been shown that patients with
periodontal disease based purely on bone loss had a 50 fold elevation in MIP-1.42 In
addition to periodontal disease and multiple myeloma, MIP-1 is associated with asthma
in which it is induced by LPS and down-regulated by drugs that up-regulate cyclic AMP,
such as -agonist and phosphodisterase inhibitors.43 Ryu et al. recently found MIP-1
expression in gingival epithelial cells was induced by LPS, and they concluded that MIP1 expression by gingival epithelial cells may be important in initiating inflammation.44
Together these studies indicate that MIP-1 may play an important role in both the early
and later stages of inflammatory related periodontitis.
Interleukin-8
Interleukin-8 (IL-8) is a chemokine produced by macrophages and epithelial cells.
It is a polypeptide with a structure consisting of seventy-two amino acids. This
chemokine is one of the major mediators of the inflammatory response and functions as a
chemoattractant.45 As a chemoattractant IL-8 presents with a profile of activity similar to
the classic peptides for chemotaxis, C5a and N-formyl-methionyl-leucyl-phenylalanine.45
The primary function of IL-8 is to recruit neutrophils to phagocytize the antigens which
trigger antigen pattern Toll-like receptors. Fitzgerald and colleagues suggested that IL-8
may play a crucial role in the recruitment and activation of neutrophils and T
lymphocytes in periodontitis, by demonstrating an elevation of IL-8 in chronically
inflamed gingival tissues.46 However it has also been demonstrated that IL-8 was found at
greater concentrations adjacent to lower sulcular depths.47 Stathopoulou studied the host
cytokine response to P. gingivalis and concluded that changes in the crevicular cytokine
profile have consequences in periodontal disease pathogenesis and may be targeted for
the development of diagnostic and therapeutic modalities.48
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CHAPTER 2.

SPECIFIC OBJECTIVES

The objective of this study was to investigate the effect of LPS isolated from three
different periodontal pathogens on the secretion of cytokines by cultured monocytes.
This study tested the hypothesis that the LPS of oral pathogens suppress the
secretion of IL-8 by host inflammatory cells thus contributing to interference with
neutrophil chemotaxis ability. In addition, the suppression of MIP-1 secretion may
reduce the ability of host defense cells to detect oral pathogens. Together these factors
may then aid the pathogenic bacteria to escape detection by the defensive cells, thus
facilitating their colonization and pathogenicity.
Specific Aim 1: Isolation and Purification of LPS and Lipid A
To Isolate the LPS from periodontal pathogens, F. nucleatum, P. gingivalis, and
P. denticola. The endotoxin activity of the isolated LPS will be determined by the
Limulus assay.
Specific Aim 2: Cytokine Expression of Il-8
To study the effect of LPS on cultured monocyte to secrete IL-8, a cytokine
known to play a key role in chemotaxis.
Specific Aim 3: Cytokine Expression of MIP-1α
To investigate the differences in LPS from periodontal pathogens, F. nucleatum,
P. gingivalis, and P. denticola, by testing their ability to stimulate or suppress another
cytokine, MIP-1, which has been recognized to be an important chemokine.
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CHAPTER 3.

MATERIALS AND METHODOLOGY
Materials

The bacteria, P. gingivalis (25260), P. denticola (33185), and F. nucleatum
(10953), were obtained from ATCC, Rockville, MD. The bacteria were grown in the
laboratory under anaerobic conditions in thioglycollate broth at 37ºC in an anaerobic jar
for 72 hours. The crystal phenol was obtained from Fischer Scientific, Pittsburgh, PA.
Limulus amebocyte lysate was purchased from the Associates of Cape Cod, Inc.
Fallmouth, MA. THP-1 cells (ATCC TIB202) were obtained from ATCC, Rockville,
MD. Stabilized chromogen and peroxide solutions were obtained from R&D Systems,
Minneapolis, MN. Commercial enzyme-linked immunosorbent assay (ELISA) kits from
R&D Systems were employed to measure the cytokines MIP-1α and IL-8 released by the
monocytes. LPS from E. coli was purchased from Sigma-Aldrich, St. Louis, MO.
Methodology
LPS Preparation
Periodontal pathogens were grown in liter batches of thioglycollate broth (Difco)
for 72 hours in an anaerobic jar. The bacteria were harvested by centrifugation and the
cell pellets were washed with physiological saline, then with de-ionized water and
centrifuged. The bacterial cell pellets were lyophilized and the LPS was prepared by the
hot phenol-water extraction method as described by Westphal and Jann.49 Batches of 0.25
g of the lyophilized bacteria were suspended in 200 ml of 90% phenol and hot water and
incubated at 67ºC for 15 minutes and then stirred for another 15 minutes on a stirrer at
room temperature. The mixture was chilled on ice to 10ºC to separate the phases. The
resultant LPS-containing aqueous phase was then collected from the lower phenol phase.
The non-aqueous phenol phase was subjected to a second extraction by adding an
additional 200 ml of water. The pooled aqueous phases were dialyzed against distilled
water at 4ºC for 48 hours. The aqueous phase was collected, and frozen, and then
lyophilized. The purity and protein contamination of the isolated LPS was confirmed by
gel electrophoresis (10% polyacrylamide gel containing 0.1% sodium dodecyl sulfate).50
LPS samples were sonicated gently prior to electrophoresis, and then the gel was stained
with silver nitrate stain.
Limulus Amoebocyte Lysate (LAL) Assays
The LPS activity of periodontal pathogens was measured with the Limulus
amoebocyte assay.51 The Limulus endotoxin assay is a test developed from the blood cells
of the horseshoe crab that detects minute amounts of endotoxins in fluids. All assays
were conducted in 96-well microplate; a computer-controlled Bio-Rad microplate reader
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was used. A turbidimetric assay was used, in which the increasing turbidity caused by the
gelation of the Limulus lysate in response to LPS was followed over time. Samples were
prepared in a volume of 0.2 ml. LPS preparations from P. denticola, F. nucleatum, and P.
gingivalis and suspended to concentrations of 0.1 to 100 ng/ml. Highly purified LPS from
E. coli K235 was used to prepare the standards over a concentration range of 0.1 ng/ml to
100 ng/ml. The assay was initiated by addition of 50µl of Limulus lystate reagent to each
well containing appropriate dilutions of LPS. The samples were read at an absorbance of
450 nm. Plots were made of the absorbance of each sample over time, and the curves
were compared with those of the E. coli LPS standards. The activity of each LPS sample
in causing gelation of Limulus lysate was expressed in units corresponding to the activity
of 1 ng/ml of E. coli LPS.
Treatment of THP-1 Cells with LPS
THP-1 are mature cells in the monocyte/macrophage lineage with a normal
diploid karyotype, and they produce several cytokines in response to purified endotoxin.
These non-adherent cells were maintained in continuous culture with RPMI 1640
(GIBCO/BRL, Grand Island, NY), 10% fetal bovine serum (GIBCO/BRL), and 0.05 mM
2-mercaptoethanol (GIBCO/BRL) in an atmosphere of 5% CO2 at 378ºC. The doubling
time for these cells under these conditions is approximately 48 h. THP-1 cells were
treated with phorbol 12-myristate 13-acetate (10-7 M; Calbiochem Co., La Jolla, Calif.) to
induce maturation of the monocytes and became macrophage-like; differentiated
macrophages were identified by morphological features and their ability to adhere to
plastic. Before experimentation or treatment with phorbol-12-myristate-13-acetate, THP1 cells were washed three times with culture medium without fetal bovine serum and
resuspended to a concentration of 1x106 cells per ml. Cell viability was determined to be
95% by the trypan blue dye exclusion assay. Different concentrations of bacterial LPS (1,
5, 10, and 20 ng/ml) were added and incubated for 72 hours. Supernatant fluids were
collected, centrifuged and assayed for the secreted cytokines, MIP-1α and IL-8 by
ELISA. Variations of this experiment were carried out with combinations of bacterial
LPS. Concentrations of 10 ng/ml of LPS from different periodontal pathogens were
added together. The LPS of one pathogen was first added to the monocytes and then at
varying intervals (baseline, 15 minutes, 30 minutes, and 60 minutes) the LPS of the
second pathogen was added and the incubation ran for 72 hours. Supernatant fluids were
collected, centrifuged and assayed for the secreted cytokines, MIP-1α and IL-8 by
ELISA.
MIP-1α Assay
THP-1 cells were prepared as described above. ELISA kits were employed to
measure the concentration of MIP-1α released from the THP-1 cells when stimulated
with LPS of P. gingivalis, P. denticola, F. nucleatum and E. coli LPS. The standard for
the MIP-1α assays was reconstituted to a concentration of 90 ng/ml with 0.5ml of reagent
diluent consisting of 1% bovine serum albumin (BSA) in phosphate buffered saline
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(PBS), pH 7.2-7.4. Upon reconstitution of the standard a stock solution was prepared in a
tube to produce the standard with a concentration of 500 pg/ml. The stock solution was
stored at 2-8ºC for no longer than 60 days. A seven point standard curve using 2 fold
serial dilutions with 1% BSA in PBS, and a high standard of 500pg/ml was utilized. The
assay dilution series was produced with the following concentrations: 500 pg/ml,
250 pg/ml, 125 pg/ml, 62.5 pg/ml, 31.25 pg/ml, 15.625 pg/ml, 7.8125 pg/ml and 3.9
pg/ml. The reagent diluent served as the zero standard. The microplates were coated with
a mouse monoclonal antibody against human MIP-1α. The concentrations of LPS tested
for the periodontal pathogens were 1ng/ml, 5ng/ml, 10 ng/ml, and 20 ng/ml. The
standard, samples and control were incubated at room temperature for 2 hours. Following
incubation, each well was aspirated and washed 4 times with wash buffer; the wash
buffer consisted of 0.05% Tween 20 in PBS. An aliquot (100 μl) of biotinylated goat
anti-human MIP-1serving as the detection antibody at a concentration of 36 μg/ml was
added to each well followed by a 2 hour incubation at room temperature. Following
incubation, each well was aspirated and washed 4 times with wash buffer. A 100 µl
working dilution of streptavidin conjugated to horseradish peroxidase was added to each
well and incubated at room temperature for 20 minutes. The aspiration and wash step was
repeated, and then 100 μl of substrate solution, consisting of a 1:1 mixture of stabilized
peroxide solution and chromagen solution was added to each well and incubated at room
temperature for 20 minutes. To stop the reaction, 50 μl of stop solution (2N H2SO4) was
added to each well and the microplates were read at 450 nm absorbance.
IL-8 Assay
THP-1 cells were prepared as described previously. ELISA kits were employed to
measure the concentration of IL-8 released from the THP-1 cells when stimulated with
LPS of P. gingivalis, P. denticola F. nucleatum and E. coli. The standard for the IL-8
assay was reconstituted to a concentration of 1100 ng/ml with 0.5 ml of distilled water.
Upon reconstitution of the standard a stock solution was prepared in a tube to produce the
standard with a concentration of 2000 pg/ml. The stock solution was stored at 2-8ºC for
no longer than 60 days. A seven point standard curve using 2 fold serial dilutions with
0.1% BSA, 0.05% Tween 20 in PBS, and a high standard of 2000 pg/ml was utilized. The
assay dilution series was produced with the following concentrations: 2000 pg/ml,
1000 pg/ml, 500 pg/ml, 250 pg/ml, 125 pg/ml, 62.5 pg/ml, 31.25 pg/ml, and
15.625 pg/ml. The reagent diluent served as the zero standard. The microplates were
coated with a mouse monoclonal antibody against human IL-8. The concentrations of
LPS tested for the periodontal pathogens were 1 ng/ml, 5 ng/ml, 10 ng/ml, and 20 ng/ml.
The standard, samples and control were incubated at room temperature for 2 hours.
Following incubation, each well was aspirated and washed 4 times with wash buffer;
consisting of 0.05% Tween 20 in PBS. An aliquot (100 μl) of biotinylated goat antihuman IL-8 serving as the detection antibody at a concentration of 3.6 μg/ml was added
to each well followed by a 2 hour incubation at room temperature. Following incubation,
each well was aspirated and washed 4 times with wash buffer. A 100µl working dilution
of streptavidin conjugated to horseradish peroxidase was added to each well and
incubated at room temperature for 20 minutes. The aspiration and wash step was repeated
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then 100 μl of substrate solution, consisting of a 1:1 mixture of stabilized peroxide
solution and chromagen solution was added to each well and incubated at room
temperature for 20 minutes. To stop the reaction, 50 μl of stop solution (2N H2SO4) was
added to each well and the microplates were read at 450 nm absorbance.
Data Analysis
Each experiment was repeated a minimum of three times, with triplicate
determinations at each data point. Control media consisting of unstimulated THP-1 cells
served as the negative control and was a blank. The negligible amount of cytokine
secretion from the negative control was automatically subtracted from the cytokines
secreted by monocytes incubated with LPS of periodontal pathogens. Mean values ±
SEM from triplicate samples were calculated and the significance of differences was
assessed using a two-tailed Student’s t-test. Differences in results with a p-value < 0.05
were considered significant.
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CHAPTER 4.

RESULTS

Limulus Activity
The endotoxin activities of LPS isolated from periodontal pathogens were
measured first with the Limulus assay.51 Stock solutions of LPS preparations from E. coli,
F. nucleatum, P. gingivalis, and P. denticola were prepared in sterile water at 10ng/ml.
These solutions were placed in an ultrasonic bath for 20 seconds before use to ensure an
uniform suspension. Samples of these LPS solutions were then tested for Endotoxin
activity by their ability to cause gelation of Limulus amoebocyte lysate over a period of
60 minutes. This is a standard measure of LPS or Endotoxin activity. The Limulus assay
uses a homogenate or lystate made from the macrophage-like amoebocytes taken from
the blue blood (hemolymph) of the horseshoe crab (Limulus polyphemus). This lysate
gels and becomes turbid in the presence of was measured at 450nm. This method has a
high degree of sensitivity and can detect 0.001 to 100ng/ml LPS. As a standard we have
used E. coli LPS. The activity of each LPS sample in causing gelation of Limulus lysate
was expressed in units corresponding to the activity of 1ng/ml of E. coli LPS. The results
(Figure 4-1) show that all four LPS preparations demonstrated measurable endotoxin
activity. The endotoxin activity of F. nucleatum, and P. gingivalis, were almost identical,
while the activity of P. denticola was slightly lower. The LPS activity of periodontal
pathogens both had about one-third activity of the highly purified E. coli LPS standard.
Influence of Periodontal Pathogens’ LPS on MIP-1 Secretion by Monocytes
This study demonstrated in repeated experiments that MIP-1αis induced by
monocytes in response to stimulation by the LPS of periodontal pathogens. The data
demonstrated that there were differences in the rate of secretion of MIP-1α. Upon
comparing the rate of secretion of MIP-1αamong the three periodontal pathogens and
E. coli it was found that MIP-1αstimulation varied dependent upon the LPS of the
specific organism stimulating the monocytes. We demonstrated that F. nucleatum LPS
stimulated the secretion of MIP-1α. However, P. gingivalis and P. denticola inhibited the
secretion of MIP-1α. Changes in the rate of secretion for MIP-1αwas directly correlated
with the concentration of LPS from periodontal pathogens.
Figure 4-2 shows the secretion of MIP-1α by monocytes to be dose-dependent
upon the concentration of the P. gingivalis LPS. The higher concentrations of P.
gingivalis LPS lead to an inhibition of MIP-1α secretion from monocytes. When the
monocytes were treated with the LPS of P. gingivalis at a concentration of 1 ng/ml the
amount of MIP-1α secreted was 73 pg/ml, at a concentration of 5 ng/ml the amount of
MIP-1α secreted was 50 pg/ml, at a concentration of 10ng/ml the amount of MIP-1α
secreted was 11 pg/ml and at a the highest concentration of 20ng/ml the average MIP-1α
secreted was 9 pg/ml. This plot demonstrates a significant decrease in the stimulation of
MIP-1α from the 1 ng/ml to 20 ng/ml concentrations.
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Figure 4-1. Endotoxin Activity of LPS Preparations from E. coli and Oral
Pathogens at 10ng/ml.
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Figure 4-2. Demonstration of Effect of Porphyromonas gingivalis LPS
Concentration on MIP-1α Secretion.
MIP-1 secretion by monocytes was found to be inhibited by LPS of P. gingivalis at
greater concentrations. The results are the mean ± the standard error, N=3 run in
triplicate.
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Figure 4-3 shows the secretion of MIP-1α by monocytes that were incubated with
1 ng/ml, 5 ng/ml, 10 ng/ml, and 20 ng/ml concentrations of LPS isolated from P.
denticola. The secretion of MIP-1α is dose dependent and as the concentrations of the
LPS of P. denticola increased there is less stimulation of MIP-1α secretion. When the
monocytes were treated with the LPS of P. denticola at a concentration of 1 ng/ml the
amount of MIP-1α secreted was 73 pg/ml, at a concentration of 5 ng/ml the amount of
MIP-1α secreted was 54 pg/ml, at a concentration of 10 ng/ml the amount of MIP-1α
secreted was 24 pg/ml and at a the highest concentration of 20ng/ml the average MIP-1α
secreted was 11 pg/ml. This plot demonstrates a significant decrease in the stimulation of
MIP-1α from the 1ng/ml to 20ng/ml concentrations.
Figure 4-4 shows the secretion of MIP-1α by monocytes that were incubated with
1 ng/ml, 5 ng/ml, 10 ng/ml, and 20 ng/ml concentrations of LPS isolated from F.
nucleatum. The secretion of MIP-1α is dose dependent and as the concentrations of the
LPS of F. nucleatum increases there is greater stimulation of MIP-1α secretion. When the
monocytes were treated with the LPS of F. nucleatum at a concentration of 1 ng/ml the
amount of MIP-1α secreted was 53 pg/ml, at a concentration of 5 ng/ml the amount of
MIP-1α secreted was 64 pg/ml, at a concentration of 10 ng/ml the amount of MIP-1α
secreted was 70 pg/ml and at a the highest concentration of 20 ng/ml the average MIP-1α
secreted was 77 pg/ml.
Figure 4-5 shows the secretion of MIP-1α by monocytes that were incubated with
1 ng/ml, 5 ng/ml, 10 ng/ml, and 20 ng/ml concentrations of LPS isolated from E. coli.
The secretion of MIP-1α is dose dependent and as the concentrations of the LPS of E.
coli increases there is greater stimulation of MIP-1α secretion. When the monocytes were
treated with the LPS of E. coli at a concentration of 1 ng/ml the amount of MIP-1α
secreted was 25 pg/ml, at a concentration of 5 ng/ml the amount of MIP-1α secreted was
55 pg/ml, at a concentration of 10 ng/ml the amount of MIP-1α secreted was 73 pg/ml
and at a the highest concentration of 20 ng/ml the average MIP-1α secreted was 91 pg/ml.
Figure 4-6 summarizes the secretion of MIP-1α by monocytes that were
incubated with 1 ng/ml, 5 ng/ml, 10 ng/ml, and 20 ng/ml concentrations of LPS isolated
from periodontal pathogens. The experiments demonstrated similarities between the LPS
of P. gingivalis and P. denticola. The LPS of these organisms inhibited the secretion of
MIP-1α. As the LPS concentration of both P. gingivalis and P. denticola increased MIP1secretion decreased significantly as compared to MIP-1α secretion via the stimulation
of monocytes with E. coli or F nucleatum LPS. F. nucleatum and E. coli. LPS
demonstrated similar results, the LPS of these organism resulted in an increase in the
secretion of MIP-1 alpha at higher concentrations. However, there were no statistical
differences in the ability of F. nucleatum and E. coli LPS to stimulate the secretion of
MIP-1cultured monocytes.
Figure 4-7 shows the secretion of MIP-1α by monocytes that were incubated with
a LPS combination consisting of 10 ng/ml F. nucleatum LPS with 5 ng/ml P. denticola
LPS, or with 10ng/ml Pd LPS. This experiment demonstrated that stimulation of MIP-1α
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Figure 4-3. Demonstration of Effect of Prevotella denticola LPS Concentration
on MIP-1α Secretion.
MIP-1secretion by monocytes was found to be inhibited by LPS of P. denticola at
greater concentrations. The results are the mean ± the standard error, N=3 run in
triplicate.
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Figure 4-4. Demonstration of Effect of Fusobacterium nucleatum LPS
Concentration on MIP-1α Secretion.
MIP-1 secretion by monocytes was found to be stimulated by LPS of F. nucleatum at
greater concentrations. The results are the mean ± the standard error, N=3 run in
triplicate.
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Figure 4-5.
Secretion.

Demonstration of Effect of E. coli LPS Concentration on MIP-1α

MIP-1 secretion by monocytes was found to be stimulated by LPS of E. coli at greater
concentrations. The results are the mean ± the standard error, N=3 run in triplicate.
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Figure 4-6. Demonstration of Effect of Periodontal Pathogen LPS Concentration
on MIP-1α Secretion.
MIP-1α secretion by monocytes was found to be stimulated by LPS of F. nucleatum and
E. coli at greater concentrations. While at the same time MIP-1α secretion was inhibited
by the LPS of P. gingivalis and P. denticola at greater concentrations.

20

80

pg/ml of MIP-1 Secreted

70
60
50
40
30
20
10
0
Fn 10ng/ml

Fn10ng/ml &
Pd5ng/ml

Fn10ng/ml &
Pd10ng/ml

F. nucleatum LPS combined with P. denticola LPS tested.
Figure 4-7. Demonstration of Effect of Fusobacterium nucleatum LPS Combined
with Prevotella denticola LPS on MIP-1α Secretion.
The stimulation of MIP-1α secretion from monocytes by Fn LPS was found to be
inhibited by combining the LPS of F. nucleatum with the LPS of P. denticola.
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secretion previously seen with F. nucleatum LPS is inhibited when in combination with
P. denticola LPS. When the monocytes were treated with a combination of 10 ng/ml
F. nucleatum LPS and 5 ng/ml P. denticola LPS the amount of MIP-1α secreted was 32
pg/ml, when treated with a combination of 10 ng/ml F. nucleatum LPS and 10 ng/ml P.
denticola LPS the amount of MIP-1α secreted was 3 pg/ml. There is a significant
reduction in the amount of MIP-1α secreted when F. nucleatum LPS is combined with P.
denticola LPS as compared to the secretion of MIP-1α by monocytes when stimulated
solely with F. nucleatum LPS. Also this experiment demonstrated a trend where higher
concentrations of P. denticola LPS when combined with F. nucleatum LPS demonstrated
a greater reduction in the secretion of MIP-1α. However, there was no statistical
difference in the secretion of MIP-1α between the varying concentrations of P. denticola
LPS.
Figure 4-8 shows the secretion of MIP-1α by monocytes that were incubated with
a LPS combination consisting of 10 ng/ml F. nucleatum LPS with 5 ng/ml P. gingivalis
LPS, and 10ng/ml P. gingivalis LPS. This experiment demonstrated that stimulation of
MIP-1α secretion previously seen with F. nucleatum LPS is inhibited when in
combination with P. gingivalis LPS. When the monocytes were treated with a
combination of 10 ng/ml F. nucleatum LPS and 5 ng/ml P. gingivalis LPS the amount of
MIP-1α secreted was 55 pg/ml, when treated with a combination of 10 ng/ml F.
nucleatum LPS and 10 ng/ml P. gingivalis LPS the amount of MIP-1α secreted was 10
pg/ml. There is a significant reduction in the amount of MIP-1α secreted when F.
nucleatum LPS is combined with P. gingivalis LPS as compared to the secretion of
MIP-1α by monocytes when stimulated solely with F. nucleatum LPS. Also this
experiment demonstrated a trend where higher concentrations of P. gingivalis LPS when
combined with F. nucleatum LPS demonstrated a greater reduction in the secretion of
MIP-1α. However, there was no statistical difference in the secretion of MIP-1α between
the varying concentrations of P. gingivalis LPS.
Figure 4-9 shows the secretion of MIP-1α by monocytes that were incubated with
a LPS combination consisting of 10ng/ml F. nucleatum LPS with 10ng/ml P. gingivalis
LPS. In this experiment the cultured monocytes were stimulated first with F. nucleatum
LPS and after 15, 30, and 60 minutes, P. gingivalis LPS was added to the cells. This
experiment demonstrated that stimulation of MIP-1α secretion previously seen with F.
nucleatum LPS is inhibited when in combination with P. gingivalis LPS. However, as
you increased the amount of time before the addition of P. gingivalis LPS, the monocytes
were stimulated and secreted greater concentrations MIP-1α. The increased secretion of
MIP-1α is directly correlated with the time delay. The longer the wait before the addition
of P. gingivalis LPS the greater the secretion of MIP-1α.
Influence of Periodontal Pathogens on Monocytes to Secrete IL-8
The goal of these experiments was to determine whether IL-8 is induced by
monocytes in response to stimulation by the LPS of periodontal pathogens and to
determine if there are any differences in the rate of secretion IL-8. The amount of IL-8

22

pg/ml of MIP-1 Secreted

80
70
60
50
40
30
20
10
0
Fn 10ng/ml

Fn10ng/ml &
Pg5ng/ml

Fn10ng/ml &
Pg10ng/ml

F. nucleatum LPS combined with P. ginigivalis LPS
tested.
Figure 4-8. Demonstration of Effect of Fusobacterium nucleatum LPS Combined
with Porphyromonas gingivalis LPS on MIP-1α Secretion.
The stimulation of MIP-1α secretion from monocytes by F. nucleatum LPS was found to
be inhibited by combining the LPS of F. nucleatum with the LPS of P. gingivalis.
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Figure 4-9. Demonstration of Effect of Fusobacterium nucleatum LPS Combined
with Porphyromonas gingivalis LPS at Timed Interval on MIP-1α Secretion.
The stimulation of MIP-1α secretion from monocytes by a combination of F. nucleatum
LPS and P. gingivalis LPS was found to stimulate the secretion of MIP-1α when the P.
gingivalis was added at delayed time intervals.
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secreted by the three periodontal pathogens selected was compared. LPS isolated from
P. gingivalis, P. denticola, and F. nucleatum was added to the cultured monocytes and
the supernatants were assayed for the secretion of IL-8 by ELISA. E. coli LPS served as
the positive control, and unstimulated cultured monocytes served as the negative control.
IL-8 Secretion by THP-1 Cells in Response to LPS of Periodontal Pathogens
IL-8 is a cytokine produced by macrophages with a potency as a chemotactic
factor equal to that of C5a. It has been demonstrated that IL-8 is a pro-inflammatory
mediator of gingivitis. In addition it is one of the major mediators of the inflammatory
response, by serving as a chemical signal that attracts neutrophils to sites of infection.
The goals of these experiments were to determine whether the isolated LPS from the
periodontal pathogens would stimulate the THP-1 cells to secrete IL-8 and to quantify the
amount of IL-8 secreted by the THP-1 cells. An ELISA assay from was employed to
measure the concentration of IL-8 released from the THP-1 cells when stimulated with
the LPS of P. gingivalis, P. denticola, and F. nucleatum. Cultured monocytes were
incubated with 1ng/ml, 5ng/ml, 10 ng/ml, and 20 ng/ml of LPS isolated for each
periodontal pathogen.
Figure 4-10 shows the secretion of IL-8 by the monocytes to be dose-dependent
upon the concentration of the LPS of P. gingivalis. As the concentrations of the LPS of
P. gingivalis increases there is less stimulation of IL-8 secretion.
Figure 4-11 shows the secretion of IL-8 by monocytes that were incubated with
1, 5, 10, and 20 ng/ml of LPS isolated from P. denticola. The secretion of IL-8 is dose
dependent and as the concentrations of the LPS of P. denticola increases there is less
stimulation of IL-8 secretion.
Figure 4-12 shows the secretion of IL-8 by monocytes that were incubated with,
5, 10, and 20 ng/ml of LPS isolated from F. nucleatum. The secretion of IL-8 is dose
dependent and as the concentrations of the LPS of F. nucleatum increases there is greater
stimulation of IL-8 secretion.
Figure 4-13 shows the secretion of IL-8 by monocytes that were incubated with
1, 5, 10, and 20 ng/ml of LPS isolated from E. coli. The secretion of IL-8 is dose
dependent and as the concentrations of the LPS of E. coli increases there is greater
stimulation of IL-8 secretion.
Figure 4-14 summarizes the secretion of IL-8 by monocytes that were incubated
with 1, 5, 10, and 20 ng/ml of LPS isolated from periodontal pathogens. The secretion of
IL-8 is inhibited by increasing concentrations of both P. gingivalis and P. denticola. In
addition the secretion of IL-8 appears to be stimulated by increasing concentrations of F.
nucleatum and E. coli, in a dose dependent manner.
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Figure 4-10. Demonstration of Effect of Porphyromonas gingivalis LPS
Concentration on IL-8 Secretion.
IL-8 secretion by monocytes was found to be inhibited by LPS of P. gingivalis at greater
concentrations. The results are the mean ± the standard error, N=3 run in triplicate.
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Figure 4-11. Demonstration of Effect of Prevotella denticola LPS Concentration on
IL-8 Secretion.
IL-8 secretion by monocytes was found to be inhibited by LPS of P. denticola at greater
concentrations. The results are the mean ± the standard error, N=3 run in triplicate.
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Figure 4-12. Demonstration of Effect of Fusobacterium nucleatum LPS
Concentration on IL-8 Secretion.
IL-8 secretion by monocytes was found to be stimulated by LPS of F. nucleatum at
greater concentrations. The results are the mean ± the standard error, N=3 run in
triplicate.
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Figure 4-13. Demonstration of Effect of E. coli LPS Concentration on IL-8
Secretion.
IL-8 secretion by monocytes was found to be stimulated by LPS of E. coli at greater
concentrations. The results are the mean ± the standard error, N=3 run in triplicate.
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Figure 4-14. Demonstration of Effect of Periodontal Pathogen LPS Concentration
on IL-8 Secretion.
IL-8 secretion by monocytes was found to be stimulated by LPS of F. nucleatum and
E. coli at greater concentrations. While at the same time IL-8 secretion was inhibited by
the LPS of P. gingivalis and P. denticola at greater concentrations.
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Effect of Periodontal Pathogens LPS Combinations on Monocytes to Secrete IL-8
In periodontal disease the periodontal pathogens are not found as individual
strains but are found in combination with numerous organisms as part of a biofilm. The
goal of these experiments was to determine whether IL-8 is induced by monocytes in
response to stimulation by the LPS of periodontal pathogen combinations and to compare
the effect of periodontal pathogen combinations on the rate of IL-8 secretion. The
amount of IL-8 secreted by the combination of F. nucleatum LPS with P. gingivalis LPS,
or F. nucleatum LPS with P. denticola LPS was compared to F. nucleatum LPS alone.
Isolated LPS combinations were added to the cultured monocytes and the supernatants
were assayed for the secretion of IL-8 by ELISA. E. coli LPS served as the positive
control.
Figure 4-15 shows the secretion of IL-8 by the monocytes to be stimulated by
F. nucleatum LPS alone. However, upon combining the F. nucleatum LPS with
P. gingivalis or P. denticola LPS there is an inhibition of IL-8 secretion. Furthermore the
greater the concentration of either P. gingivalis or P. denticola the greater the inhibition
of IL-8 secretion. The results indicate that the LPS of both P. gingivalis and P. denticola
may have a greater affinity for the LPS binding site on the monocytes, than the LPS of
F. nucleatum, thus causing the inhibition of cytokine secretion.
Figure 4-16 shows the secretion of IL-8 by monocytes that were incubated with a
LPS combination consisting of 10ng/ml F. nucleatum LPS with 10ng/ml P. gingivalis
LPS. In this experiment the cultured monocytes were stimulated first with F. nucleatum
LPS and after 15, 30, and 60 minutes, P. gingivalis LPS was added to the cells. This
experiment demonstrated that stimulation of IL-8 secretion previously seen with F.
nucleatum LPS is inhibited when in combination with P. gingivalis LPS at baseline.
However, as you increased the amount of time before the addition of P. gingivalis LPS,
the monocytes were stimulated and secreted greater concentrations of IL-8. The increased
secretion of IL-8 is directly correlated with the time delay. The longer the wait before the
addition of P. gingivalis LPS the greater the secretion of IL-8. The results showed that
when the monocytes were first incubated with F. nucleatum LPS challenging with
P. gingivalis LPS at a later time had no significant inhibitory effect on cells to secrete IL8. The data suggests that the two LPS molecules appears to bind to the same LPS binding
site on the monocytes.
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Figure 4-15. Demonstration of Effect of Fusobacterium nucleatum LPS in
Combination with Porphyromonas gingivalis LPS or Prevotella denticola LPS
Concentrations on IL-8 Secretion.
IL-8 secretion by monocytes was found to be stimulated by LPS of F. nucleatum. Upon
combining F. nucleatum LPS with P. gingivalis or P. denticola LPS IL-8 secretion was
inhibited. At greater concentrations of both P. gingivalis and P. denticola LPS there was
greater inhibition of IL-8 secretion.
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Figure 4-16. Demonstration of Effect of Fusobacterium nucleatum LPS Combined
with Porphyromonas gingivalis LPS at Timed Interval on IL-8 Secretion.
The stimulation of IL-8 secretion from monocytes by a combination of F. nucleatum LPS
and P. gingivalis LPS was found to stimulate the secretion of IL-8 when the
P. gingivalis was added at delayed time intervals.
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CHAPTER 5.

DISCUSSION

The first line of defense against an infection consists of the recruitment of
monocytes and neutrophils. These cells are the most common leukocytes in circulating
blood, representing greater than fifty percent of the cells. In this study cultured
monocytes were exposed to the LPS isolated from P. gingivalis, P. denticola, and
F. nucleatum and the ability of the monocytes to secrete the cytokines IL-8 and
chemokine MIP-1was determined. It has been shown that the regulation of leukocyte
migration into and through the tissues is determined by the expression of adhesion
molecules, mainly on endothelial cells, which are induced by pro-inflammatory
cytokines, as well as a group of cytokines with chemotactic properties, the chemokines.
Chemokines are responsible for the recruitment and subsequent activation of particular
leucocytes into inflamed tissues and therefore play a central role in the final outcome of
the immune response by determining which subsets of leucocytes form the inflammatory
infiltrate.54
Previous studies conducted in our laboratory demonstrated differences in
biological functions of LPS. LPS isolated from P. gingivalis, P. denticola and
P. intermedia failed to prime neutrophils. Furthermore, these LPS molecules also
inhibited production of superoxide ions by the neutrophils. On the other hand the LPS of
F. nucleatum and E. coli both primed the neutrophils readily and had no negative effect
on the production of superoxide ions. We hypothesized that pathogenic bacteria appear to
be “stealthy” by avoiding stimulation of neutrophils thus escaping phagocytosis. Such
“stealthy” nature of LPS would aid the pathogens to colonize the host gingival tissues
readily, and cause tissue destruction.
The LPS samples isolated from three periodontal pathogens demonstrated very
slightly diminished but similar endotoxin activity as E. coli when tested with the Limulus
assay. The results showed that the LPS endotoxin activity of periodontal pathogens in
general had lower endotoxin activity than the LPS of E. coli. It required at least 3-fold
greater amount of LPS of periodontal pathogens to reach the level of activity attained by
the LPS of E. coli. Studies have shown that the variation in endotoxin activity of LPS
was attributed to the lipid A structure, which seems to vary among certain bacteria.53
Nevertheless, in the present study there were no differences in endotoxin activity between
the three periodontal pathogens. Previous studies from our laboratory demonstrated that
even though all the LPS preparations had similar endotoxin activity, their functions seem
to differ from each other.
The Secretion of MIP-1 by THP-1 Cells in Response to LPS of Periodontal
Pathogens
MIP-1α is a heparin-binding protein, with a molecular weight of 6-8 kDa, known
to exhibit a number of inflammatory and immunoregulatory activities. MIP-1α is a
member of a super family of cytokines called chemokines, and has been shown to
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mediate chemotactic activity for inflammatory and immune effector cells. MIP-1α also
plays a role in regulating hematopoiesis and stimulating production of other
inflammatory mediators such as IL-1, TNF-α, and histamine.37 While MIP-1α was
originally identified as a secretory product of endotoxin-stimulated mouse macrophages,
these chemokines are produced by a variety of cell types including neutrophils,
fibroblasts, endothelial and epithelial cells.39 In the present investigation we studied the
secretion of MIP-1α from cultured monocytes.
The results of our investigation demonstrated unique differences among the LPS
of tested periodontal pathogens to stimulate MIP-1α secretion from monocytes. The
results showed lower concentrations of LPS from P. gingivalis and P. denticola induced
the monocytes to secrete approximately twice as much MIP-1α than that of F. nucleatum.
However as the concentrations of LPS from P. gingivalis and P. denticola increased there
was a significant degree of inhibition in the secretion of MIP-1. From these results one
would expect as periodontitis progresses and as higher concentrations of the pathogenic
bacteria are cultured from sites of infections one would see a decrease in the secretion
MIP-1α due to P. gingivalis or P. denticola LPS stimulation.
In the literature extensive research has been carried out in the area of periodontal
inflammatory mediators. There have been very few studies on the role of the host
immune response in the presence of chemokines. There are a limited number of studies
that correlate the extent and severity of periodontitis with the secretion of MIP-1. Fine
et al.42 is one such study which looked at patients with periodontitis and measured the
secretion of MIP-1 from periodontally involved sites. They found a 50 fold increase in
levels of MIP-1 from the active sites as compared to non-active sites. This is contrary to
what was observed in the present study. However some of the difference may be
explained by the fact that in the study by Fine et al., patients at risk for aggressive
periodontitis were reported and the organism cultured from these active sites was limited
to Aa. The organisms associated with this investigation included P. gingivalis,
F. nucleatum, and P. denticola, which are associated more with chronic periodontitis as
opposed to aggressive periodontitis. Studies by Hamada et al. have demonstrated the LPS
of Gram-negative bacteria do differ structurally and functionally, and the bacteria can
modify their structure to elude the host’s immune defenses.55 This may explain why P.
gingivalis and P. denticola LPS behaved differently than F. nucleatum LPS in this
investigation and differently from Aa in the study by Fine et al.42
Ryu examined the secretion of MIP-1αin active peri-implantitis sites.44 It has
been demonstrated that peri-implantitis sites have a bacterial profile comparable to
chronic periodontitis sites. Ryu’s study appears to agree with Fine et al., subjects with a
higher plaque index demonstrated a greater secretion MIP-1α, and sites that demonstrated
clinical evidence of peri-implantitis also presented with an increased secretion of
MIP-1. Owing to different study designs, there have been differences between some of
the results of the present investigation and those of Ryu and Fine et al. Values were not
comparable because of the conditions in which studies were conducted.
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In the present investigation the results demonstrated the degree of inhibition of
MIP-1α secretion by monocytes to be dose-dependent, with the higher concentration of
LPS of P. gingivalis and P. denticola yielding greater inhibition of the monocytes ability
to secrete MIP-1α. These results suggest that as the LPS from the more pathogenic
bacteria may bind to the CD14 receptor and exert an inhibitory effect on the secretion of
MIP-1α.
The Secretion of IL-8 by THP-1 Cells in Response to LPS of Periodontal Pathogens
IL-8 is a chemokine that is important in the regulation of the inflammatory
response for its ability to recruit and activate acute inflammatory cells. It is able to
mediate the activation and migration of neutrophils, giving it a central role in the
defensive line against periodontal pathogens. IL-8 can be induced by multiple stimuli
including LPS, live bacteria, and pro-inflammatory cytokines such as TNF and IL-1.45 It
is secreted by a wide range of cells such as macrophages, monocytes, fibroblast, and
epithelial cells.47 In the present investigation we examined the secretion of IL-8 from
monocytes stimulated with LPS from P. gingivalis, P. denticola, and F. nucleatum.
The results of our investigation demonstrated unique differences among the LPS
of tested periodontal pathogens to stimulate IL-8 secretion from monocytes. The results
showed similar concentrations of LPS from P. gingivalis and P. denticola induced the
monocytes to secrete IL-8 at 1ng/ml concentrations. However as the concentrations of
LPS from P. gingivalis and P. denticola increased, the secretion of IL-8 was inhibited.
The inhibition of IL-8 was a dose dependent inhibition with the greatest concentrations of
LPS from P. gingivalis and P. denticola yielding the lowest secretion of IL-8. It is
difficult to compare our results with other studies because of the degree of variation
between our study and other studies. Many studies used cell types other than monocytes
to measure the secretion of IL-8. Also variation in the LPS isoform used in different
studies was often unclear. Coats et al. demonstrated that different P. gingivalis LPS
isoforms have been reported to have much lower bioactivity, and some of them may
antagonize the Toll-like receptors.56 In contrast to our results, Yumoto et al. demonstrated
an increase in the secretion of IL-8 upon stimulation with periodontal pathogens;57
however, in that study the secretion of IL-8 was measured from gingival epithelial cells,
and the periodontopathic bacterium Eikenella corrodens was utilized.57
Neutrophil recruitment to sites of infection is a critical element of the innate
immune response. IL-8 has been the most widely acknowledged neutrophil
chemoattractant.46 It has been shown that respiratory failure and airway damage in cystic
fibrosis patients result from increased production of IL-8, neutrophilic infiltration, and an
excessive immune response.45 Increased and deregulated recruitment and over- activation
of neutrophils have been shown to contribute to tissue damage in chronic inflammatory
disorders. In our study IL-8 secretion was inhibited by P. gingivalis and P. denticola.
This reduction of IL-8 may yield an insufficient immune response. We speculate that the
ability of these periodontal pathogens to inhibit the secretion of IL-8 may enable the
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bacteria to evade the host response and utilize other virulence factors that lead to the
breakdown of the periodontal tissues.
The Secretion of IL-8 and MIP-1 in the Presence of F. nucleatum LPS
Periodontal disease is not a disease caused by a single periodontal pathogen but
rather an interplay between numerous microbiota present in the subgingival plaque and
the host responses. Dental plaque is a complex and dynamic microbial community that
forms a biofilm on teeth, and harbors more that 700 distinct species F. nucleatum is a
prominent component quantitatively and is one of the first Gram-negative species to
become established in plaque biofilms.19 It is a central species in physical interactions
between Gram-positive and Gram-negative species that are likely to be important in
biofilm colonization, and contributes to the reducing conditions necessary for the
emergence of oxygen-intolerant anaerobes. F. nucleatum is also consistently associated
with, and is increased in number, at sites of periodontitis. However it is not directly
responsible for destructive periodontal disease, nor tooth loss. In our study we observed
that F. nucleatum LPS stimulated the secretion of the tested cytokines, in contrast to P.
gingivalis and P. denticola which inhibited IL-8 and MIP-1. To better simulate the
conditions of a biofilm we tested the response of the monocytes to secrete cytokines in
the presence of a challenge from the LPS of F. nucleatum combined with either P.
gingivalis or P. denticola LPS. We found that F. nucleatum LPS when added to either
P. gingivalis of P. denticola LPS responded by inhibiting the secretion of both IL-8 and
MIP-1.
There are a few studies in the literature that examine the effects of combining
F .nucleatum with other periodontal pathogens. Saito et al. demonstrated that
F.nucleatum enhances the invasion of P. gingivalis in endothelial cells.58 This appears to
be in accord with what we would expect from the results of our study. However, again it
is difficult to compare that study with the results of the present investigation due to
difference in the study design.
We further challenged the monocytes with F. nucleatum LPS combined with
either P. gingivalis or P. denticola LPS at 15 minute intervals. The results demonstrated
an increase in the secretion of both IL-8 and MIP-1cytokines by the monocytes. This
appears to indicate that F. nucleatum LPS may bind to the same receptor as that of
P. gingivalis and P. denticola. Enabling F. nucleatum to block the inhibition of cytokine
secretion from the monocytes that was previously demonstrated by both the LPS of
P. gingivalis and P. denticola when added either simultaneously to F. nucleatum LPS or
independently of F. nucleatum LPS. Since periodontal disease is a polymicorobial
infection and because F. nucleatum is one of the earlier microorganisms isolated from
periodontitis. This experiment better simulates what is taking place in vivo in periodontal
disease and the results appear to correlate well with the literature which tends to
demonstrate an overall increase in the secretion of MIP-1 and IL-8 in periodontal
disease.40,41,42,44
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